Publications | Lund University Publications

1 – 10 of 22

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22medk-smu%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor+exact+%22medk-smu%22)&q=subject+exact+%2230301%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2024
Mark Broken beyond repair: self regulation of industry payments to clinicians and hospitals
Ozieranski, Piotr and Mulinari, Shai ^LU (2024) In BMJ: British Medical Journal 386.
- Contribution to journal › Debate/Note/Editorial
Mark Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019 : A content analysis
Larkin, James ; Matthes, Britta ; Azribi, Mohamed ; Kearns, Conor ; Mulinari, Shai ^LU ; Rickard, Emily ; Moriarty, Frank ; Fahey, Tom and Ozieranski, Piotr (2024) In Health Policy 149(November 2024).
- Contribution to journal › Article
Mark Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019 : An observational study
Larkin, James ; Mulinari, Shai ^LU ; Ozieranski, Piotr ; Lynch, Kevin ; Fahey, Tom ; Ozaki, Akihiko and Moriarty, Frank (2024) In Health Policy and Technology 13(2).
- Contribution to journal › Article
2023
Mark Unethical pharmaceutical marketing: a common problem requiring collective responsibility
Mulinari, Shai ^LU and Ozieranski, Piotr (2023) In BMJ (Clinical research ed.) 382.
- Contribution to journal › Article
Mark Pharmaceutical industry payments to NHS trusts in England : A four-year analysis of the Disclosure UK database
Ozieranski, Piotr ; Saghy, Eszter and Mulinari, Shai ^LU (2023) In PLoS ONE 18(11).
- Contribution to journal › Article
Mark International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
Ozieranski, Piotr ; Saito, Hiroaki ; Rickard, Emily ; Mulinari, Shai ^LU and Ozaki, Akihiko (2023) In Globalization and Health 19(14). p.1-42
- Contribution to journal › Article
2022
Mark Tip of the iceberg? Country- and company-level analysis of drug company payments for research and development in Europe
Ozieranski, Piotr ; Martinon, Luc ; Jachiet, Pierre-Alain and Mulinari, Shai ^LU (2022) In International Journal of Health Policy and Management 11(12). p.2842-2859
- Contribution to journal › Article
Mark Content and strength of conflict of interest policies at Scandinavian Medical Schools: a cross sectional study
Fabbri, Alice ; Mulinari, Shai ^LU ; Johansson, Martin ^LU ; Ghaur, Weda ; Khalil, Abdullah Muhammad and Lundh, Andreas (2022) In BMC Medical Education 22.
- Contribution to journal › Article
Mark Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Mulinari, Shai ^LU ; Pashley, Dylan ^LU and Ozieranski, Piotr (2022) In Health Policy 126(12). p.1256-1262
- Contribution to journal › Article
2021
Mark Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: A European policy review
Ozieranski, Piotr ; Martinon, Luc ; Jachiet, Pierre-Alain and Mulinari, Shai ^LU (2021) In BMJ Open 11.
- Contribution to journal › Article

« previous
1
2
3
next »

your query:: Remove author: Mulinari, Shai (LU); Remove subject: Health Care Service and Management, Health Policy and Services and Health Economy